Individual Genome Sequencing

Illumina was founded in 1998 with the vision of becoming the world’s leading provider of integrated tools and services that advance the understanding of genetics and health. Today, our platforms and assays are helping make studies possible that were not even imaginable just a few years ago. Whether enabling researchers to discovering the genetic underpinnings of disease risk or individuals to better understand their genome, our technologies provide the most accurate, comprehensive translation of what's present in our DNA.

Your genome. Your story.

Sequencing and Genotyping For years, researchers have been able to increase the pace of their genetic research and advance their understanding of DNA using Illumina leading-edge technologies. Now you can take advantage of this same world-class technology with the Individual Genome Sequencing (IGS) service. IGS truly starts with you. Think of your genome as a book. It tells a story—one that is unique to you. With IGS, we provide you with a means to read your story. We empower you to understand yourself in new ways.

First Name: *
Last Name: *
Country: *
Email: *
Reason for Inquiry: *
Comments:

SUBMIT

Illumina

This lab developed test was developed, and its performance characteristics were determined, by the Illumina Clinical Services Laboratory (CLIA-certified, CAP-accredited). Consistent with lab developed tests, it has not been cleared or approved by the U.S. Food and Drug Administration. You will not receive from Illumina medical results, or a diagnosis, or recommendation for treatment. Please note that Illumina does not accept orders for Individual Genome Sequencing services from the following states: Florida, Maryland, New York, and Rhode Island.